Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infections, Bacterial”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05926466
What this trial is testing

BTZ-043 Dose Evaluation in Combination and Selection

Who this might be right for
Tuberculosis, PulmonaryOther Specified Pulmonary Tuberculosis
Michael Hoelscher 90
Testing effectiveness (Phase 2)UnknownNCT03357666
What this trial is testing

Clinical Study to Evaluate the Efficacy of HUDC_VT in Patients With Bacterial Vaginosis

Who this might be right for
Bacterial VaginosisHUDC_VTHaudongchun
Haudongchun Co., Ltd. 150
Not applicableEnded earlyNCT03173053
What this trial is testing

S. Aureus Decolonization in HPN Patients.

Who this might be right for
Staphylococcus AureusMotility Disorder
Radboud University Medical Center 63
Large-scale testing (Phase 3)Study completedNCT00453570
What this trial is testing

Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months

Who this might be right for
DiphtheriaTetanusHaemophilus Influenzae Type b+2 more
Sanofi 792
Large-scale testing (Phase 3)Study completedNCT06120751
What this trial is testing

A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over

Who this might be right for
Tetanus
CanSino Biologics Inc. 1,000
Very early researchStudy completedNCT04768829
What this trial is testing

Antifungal Potential of Moringa Olifera Against Otomycosis

Who this might be right for
Otomycosis
Deraya University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05139602
What this trial is testing

Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Who this might be right for
Hidradenitis Suppurativa
AbbVie 210
Large-scale testing (Phase 3)Study completedNCT02418845
What this trial is testing

SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis

Who this might be right for
Bacterial Vaginosis
Symbiomix Therapeutics 189
Not applicableStudy completedNCT03683745
What this trial is testing

Integrated Mapping of Skin-presenting Neglected Tropical Diseases in Liberia

Who this might be right for
LeprosyBuruli UlcerYaws+1 more
London School of Hygiene and Tropical Medicine 56,285
Testing effectiveness (Phase 2)Study completedNCT00679770
What this trial is testing

Study of Different Doses of a Novel Treatment for Onychomycosis

Who this might be right for
Distal, Subungual Onychomycosis
Pfizer 28
Not applicableLooking for participantsNCT07117370
What this trial is testing

Assessing the Feasibility of Coach Mpilo for Men With TB and HIV

Who this might be right for
TuberculosisHIV
Arizona State University 240
Not applicableLooking for participantsNCT07261969
What this trial is testing

CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in Kyrgyzstan

Who this might be right for
Respiratory Tract Infection BacterialRespiratory Tract Infection ViralAMR+2 more
Rigshospitalet, Denmark 1,050
Testing effectiveness (Phase 2)Study completedNCT01215851
What this trial is testing

Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) (NC-001)

Who this might be right for
Pulmonary Tuberculosis
Global Alliance for TB Drug Development 85
Testing effectiveness (Phase 2)Study completedNCT00626795
What this trial is testing

Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)

Who this might be right for
ImpetigoSecondarily Infected Traumatic Lesions
LEO Pharma 773
Large-scale testing (Phase 3)Study completedNCT00750139
What this trial is testing

Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Pedis

Who this might be right for
Tinea PedisAthlete's Foot
Merz North America, Inc. 707
Large-scale testing (Phase 3)Study completedNCT01341639
What this trial is testing

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)

Who this might be right for
Bacterial InfectionsVirus Diseases
MCM Vaccines B.V. 1,250
Not applicableLooking for participantsNCT06311006
What this trial is testing

Safety Registry of a Fecal Microbiota Transplant Cohort

Who this might be right for
Clostridium Difficile Infections
Assistance Publique - Hôpitaux de Paris 305
Not applicableStudy completedNCT00799591
What this trial is testing

French Study In ICU Patients Treated With Tigecycline

Who this might be right for
Bacterial Infections
Wyeth is now a wholly owned subsidiary of Pfizer 156
Testing effectiveness (Phase 2)Looking for participantsNCT07285213
What this trial is testing

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

Who this might be right for
Clostridioides Difficile Infection
AstraZeneca 230
Early research (Phase 1)Study completedNCT03562117
What this trial is testing

Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function

Who this might be right for
Infections, Bacterial
GlaxoSmithKline 25
Next Page